首页 正文

Leveraging drug-target Mendelian randomization for tailored lipoprotein-lipid lowering

{{output}}
Purpose of review: The study of naturally occurring genetic variation in human populations has laid the foundation for proprotein converts subtilisin/kexin type 9 inhibitors, and more recently new classes of lipid-lowering drugs ... ...